Skip to main content

Day: December 26, 2019

INNSUITES HOSPITALITY TRUST (IHT) – DIVERSIFICATION, YTD PROFITS. THIRD QUARTER.

Phoenix, AZ, Dec. 26, 2019 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) IHT reported fiscal third quarter revenues of approximately $1.50 million for the three months August 1, 2019 to October 31, 2019 up slightly from revenues of approximately $1.49 million for the same prior year period. Basic earnings per share for the three months ended October 31, 2019 was ($0.02) compared with $2.00 for the three months ended October 31, 2018, which reflected profitable asset sales.For the 12-month trailing periods November 1, 2018 to October 31, 2019, and November 1, 2017 to October 31, 2018, total revenue was approximately $6.5 million, up sharply from approximately $12.0 million in the prior 12-month period. Total reported earnings were approximately $658,000. This compared to earnings of approximately $8,274,000...

Continue reading

Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infection

DUBLIN, Ireland and CHICAGO, Dec. 26, 2019 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced the completion of patient enrollment in its Sulopenem for Resistant Enterobacteriaceae (SURE) 1 clinical trial in uncomplicated urinary tract infections (uUTI).“We are pleased to announce the completion of enrollment in our final phase 3 trial for uncomplicated urinary tract infections (uUTI) with over 1,670 patients treated. Topline results from this trial are expected in the first quarter of 2020,” said Corey Fishman, Chief Executive Officer of Iterum Therapeutics. “It has been over 20...

Continue reading

Stable Road Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 30, 2019

NEW YORK, NY, Dec. 26, 2019 (GLOBE NEWSWIRE) — Stable Road Acquisition Corp. (the “Company”) announced that, commencing December 30, 2019, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock (“Class A Common Stock”) and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols “SRAC” and “SRACW,” respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol “SRACU.” Holders of units will need to have their brokers contact...

Continue reading

RLH Corporation Appoints R. Carter Pate as Chairman

DENVER, Dec. 26, 2019 (GLOBE NEWSWIRE) — RLH Corporation (NYSE:RLH) today announced Robert Wolfe will be retiring from the Board of Directors on December 31, 2019. The Board of Directors has selected independent director R. Carter Pate (“Carter”), who has been a board member since May 2019, as Chairman. The Board and Mr. Wolfe believe this transition is opportune as the Company launches its search for a permanent Chief Executive Officer. The Board thanks Bob for his dedicated leadership over the last seven years as RLHC embarked on its strategic evolution to a fee-based franchise business model. Mr. Pate will assume responsibilities as Chairman effective December 26, 2019.Mr. Wolfe commented, “As I considered RLHC’s ongoing evolution and my retirement plans, I determined that this would be an appropriate...

Continue reading

Two Recycled Water Projects for California Water Service Group Subsidiaries Included in House Bill 5302 (McNerney, CA-09)

SAN JOSE, Calif., Dec. 26, 2019 (GLOBE NEWSWIRE) — In a collective effort to develop sustainable sources of water supplies in California and Hawaii, California Water Service Group (NYSE: CWT) subsidiaries California Water Service (Cal Water) and Hawaii Water Service (Hawaii Water) have each proposed a recycled water project that is included in Rep. Jerry McNerney’s (CA-09) new federal bill, the “Western Water Recycling and Drought Relief Act.” Bill H.R. 5302, designed to strengthen these states’ water infrastructure by adding a total of almost 20,000 acre-feet of new water supplies, includes 12 projects from utilities that are part of the Western Recycled Water Coalition; if the bill is enacted, it will offset the costs for the utilities to design, plan, and construct the facilities.Cal Water’s King City...

Continue reading

Flexion Therapeutics Announces FDA Approval of sNDA to Revise ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Product Label

Conference call scheduled for Friday, December 27, 2019 at 8:00 a.m. ETBURLINGTON, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the product label for ZILRETTA (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA) knee pain.Key elements of the label update include:Removal of language which stated that ZILRETTA was “not intended for repeat administration.” The updated label states that the “efficacy and safety of repeat administration of ZILRETTA have not been demonstrated.”Inclusion of a study description and safety data from the single-arm, open-label Phase 3 repeat administration trial.Removal...

Continue reading

Kura Sushi Opens New Restaurant in Katy, TX

IRVINE, Calif., Dec. 26, 2019 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a fast-growing technology-enabled Japanese restaurant concept, today announced that it opened its 24th location on December 21, 2019, in Katy, TX.Located at 23330 Grand Circle Blvd., Suite 120, Katy, TX 77449, the 3,520 square foot restaurant has seating for 119 guests and employs approximately 40 team members. As part of Kura’s new design concept, the Katy location features contemporary fixtures and reflects an enhanced Japanese influence.“The Katy opening marks our 8th store in the Texas market and our 24th restaurant nationwide,” said Hajime “Jimmy” Uba, President and CEO of Kura Sushi USA. “We are excited to bring our distinctive “Kura Experience”...

Continue reading

Better Choice Company Provides Financial Update on Halo, Purely for Pets® Acquisition

On an annualized basis, Halo is generating Net Sales of $33.4 millionBetter Choice has appointed Mr. John M. Word, III and Mr. Clinton Gee to the Board of DirectorsNEW YORK, Dec. 26, 2019 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an animal health and wellness CBD company, today is providing shareholders with a financial update of its previously announced acquisition of holistic pet foods leader Halo, Purely for Pets® (“Halo®”).On an annualized basis, Halo is currently generating Net Sales of approximately $33.4 million. This is based on the company’s unaudited fiscal year-to-date results (July 1, 2019 to November 30, 2019), which Net Sales is approximately $13.9 million.Better Choice has also appointed Mr. John M. Word, III and...

Continue reading

Abeona annonce la clôture d’une offre publique souscrite de 103,5 millions de dollars et le plein exercice de l’option d’achat d’actions supplémentaires par les souscripteurs

NEW YORK et CLEVELAND, 26 déc. 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), un leader pleinement intégré en thérapie génique et cellulaire, a annoncé aujourd’hui la clôture de son offre publique souscrite, avec un produit brut d’environ 103,5 millions de dollars, qui inclut le plein exercice de l’option d’achat de 5 400 000 actions ordinaires supplémentaires par les souscripteurs, à un prix initial de 2,50 dollars par action. En outre, dans le cadre de l’offre, Abeona a vendu à Great Point Partners (« GPP »), un investisseur existant, des bons de souscription préfinancés en vue d’acheter un total de 9 017 055 actions ordinaires...

Continue reading

Abeona gibt Abschluss von garantiertem öffentlichen Zeichnungsangebot in Höhe von 103,5 Mio. USD und vollständige Ausübung der Zeichnungsoption zum Erwerb weiterer Aktien durch Konsortialbanken bekannt

NEW YORK und CLEVELAND, Dec. 26, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), ein vollständig integrierter Marktführer im Bereich der Gen- und Zelltherapie, hat heute den Abschluss seines garantierten öffentlichen Zeichnungsangebots mit einem Bruttoemissionsvolumen von ca. 103,5 Mio. USD zu einem Emissionspreis von 2,50 USD je Aktie bekanntgegeben, das die vollständige Ausübung der Zeichnungsoption zum Kauf von 5.400.000 zusätzlichen Stammaktien durch die Konsortialbanken umfasst. Darüber hinaus hat Abeona im Rahmen der Emission vorfinanzierte Optionsscheine an Great Point Partners („GPP“), einen bestehenden Investor, zum Kauf von insgesamt 9.017.055 Stammaktien zu einem Kaufpreis von 2,4999 USD pro vorfinanziertem Optionsschein verkauft, was dem Emissionspreis je...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.